These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31853554)

  • 1. Elimination or Resurgence: Modelling Lymphatic Filariasis After Reaching the 1% Microfilaremia Prevalence Threshold.
    Prada JM; Davis EL; Touloupou P; Stolk WA; Kontoroupis P; Smith ME; Sharma S; Michael E; de Vlas SJ; Hollingsworth TD
    J Infect Dis; 2020 Jun; 221(Suppl 5):S503-S509. PubMed ID: 31853554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.
    Rao RU; Nagodavithana KC; Samarasekera SD; Wijegunawardana AD; Premakumara WD; Perera SN; Settinayake S; Miller JP; Weil GJ
    PLoS Negl Trop Dis; 2014; 8(11):e3281. PubMed ID: 25393404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technical measures of filariasis elimination in Tengzhou City].
    Ma XW; Zhang XQ; Xu YL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(4):232-4. PubMed ID: 12568031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulating a Transmission Assessment Survey: An evaluation of current methods used in determining the elimination of the neglected tropical disease, Lymphatic Filariasis.
    Weiss PS; Michael E; Richards FO
    Int J Infect Dis; 2021 Jan; 102():422-428. PubMed ID: 33130207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
    Dorkenoo AM; Sodahlon YK; Bronzan RN; Yakpa K; Sossou E; Ouro-Medeli A; Teko M; Seim A; Mathieu E
    Bull Soc Pathol Exot; 2015 Aug; 108(3):181-7. PubMed ID: 25476256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The resurgence of lymphatic filariasis in the Nile delta.
    Harb M; Faris R; Gad AM; Hafez ON; Ramzy R; Buck AA
    Bull World Health Organ; 1993; 71(1):49-54. PubMed ID: 8440037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities.
    Biritwum NK; Frempong KK; Verver S; Odoom S; Alomatu B; Asiedu O; Kontoroupis P; Yeboah A; Hervie ET; Marfo B; Boakye DA; de Vlas SJ; Gyapong JO; Stolk WA
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007115. PubMed ID: 31398203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions to the lymphatic filariasis elimination programme and post-elimination surveillance in China by NIPD-CTDR.
    Sun DJ; Fang Y; Huang Y; Zhang Y
    Adv Parasitol; 2020; 110():145-183. PubMed ID: 32563324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis.
    Harris JR; Wiegand RE
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005610. PubMed ID: 28542274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models.
    Stolk WA; Prada JM; Smith ME; Kontoroupis P; de Vos AS; Touloupou P; Irvine MA; Brown P; Subramanian S; Kloek M; Michael E; Hollingsworth TD; de Vlas SJ
    Clin Infect Dis; 2018 Jun; 66(suppl_4):S260-S266. PubMed ID: 29860286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with failing pre-transmission assessment surveys (pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis.
    Burgert-Brucker CR; Zoerhoff KL; Headland M; Shoemaker EA; Stelmach R; Karim MJ; Batcho W; Bougouma C; Bougma R; Benjamin Didier B; Georges N; Marfo B; Lemoine JF; Pangaribuan HU; Wijayanti E; Coulibaly YI; Doumbia SS; Rimal P; Salissou AB; Bah Y; Mwingira U; Nshala A; Muheki E; Shott J; Yevstigneyeva V; Ndayishimye E; Baker M; Kraemer J; Brady M
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008301. PubMed ID: 32479495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the Evidence for Lymphatic Filariasis Elimination.
    Davis EL; Reimer LJ; Pellis L; Hollingsworth TD
    Trends Parasitol; 2019 Nov; 35(11):860-869. PubMed ID: 31506245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration.
    McLure A; Graves PM; Lau C; Shaw C; Glass K
    Epidemics; 2022 Sep; 40():100591. PubMed ID: 35816826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa.
    Won KY; Robinson K; Hamlin KL; Tufa J; Seespesara M; Wiegand RE; Gass K; Kubofcik J; Nutman TB; Lammie PJ; Fuimaono S
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006347. PubMed ID: 29522520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping is a prerequisite for elimination of filariasis and effective targeting of filarial 'hot spots'.
    Chand G; Kaushal LS; Choudhari NK; Singh N
    Pathog Glob Health; 2016; 110(4-5):157-63. PubMed ID: 27413817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of alternative surveillance approaches for lymphatic filariasis in low prevalence settings: Implications for post-validation settings.
    Riches N; Badia-Rius X; Mzilahowa T; Kelly-Hope LA
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008289. PubMed ID: 32396575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphatic filariasis in Hubei Province: from prevailing to elimination].
    Zhan FX; Zhang SQ; Wang LL; Yuan FY; Zhang HX; Dong XR; Li KJ; Yu PH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Feb; 30(1):65-70. PubMed ID: 22913195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of microfilaremia in bancroftian filariasis after diethylcarbamazine citrate therapy.
    Eberhard ML; Lowrie RC; Lammie PJ
    Trop Med Parasitol; 1988 Jun; 39(2):128-30. PubMed ID: 3051291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
    Rao RU; Samarasekera SD; Nagodavithana KC; Punchihewa MW; Ranasinghe USB; Weil GJ
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007365. PubMed ID: 31009482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.